Evidence mapPaperPMID 39041630Full record

ArticleEnvironmental toxicology2025

Combining Network Pharmacology and Experimental Verification to Ascertain the Mechanism of Action of Asparagus officinalis Against the Brain Damage Caused by Fluorosis.

Feiqing Wang, Yang Liu, Yanju Li, Xu Yang, Jianing Zhao, Bo Yang, Dongxin Tang, Chike Zhang, Zhixu He, Dong Ming and 1 more

Abstract read
In one paragraph

Article in Environmental toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Polysaccharides fromFrontiers in pharmacology · 2026
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Feiqing WangAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0002-4297-1839
Yang LiuClinical Research Center, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Yanju LiDepartment of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Xu YangClinical Research Center, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Jianing ZhaoClinical Research Center, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Bo YangClinical Research Center, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Dongxin TangClinical Research Center, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Chike ZhangDepartment of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Zhixu HeNational & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, Guiyang, Guizhou, China.
Dong MingAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
Xiaodong ZhuAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.

Funding

Natural Science Foundation of Guiyang City [2022]4-3-10Natural Science Foundation of Guiyang City [2022]4-3-2Natural Science Foundation of Guizhou Province QianKeHe Basics -ZK[2023] Key 042Natural Science Foundation of Guizhou Province Qiankehe Cooperation Platform talents [2021] Postdoctoral Station 007Natural Science Foundation of Guizhou Province QianKeHe Support [2022]181Research Project of Education Department of Guizhou Province QianJiaoJi [2023]037Subject Excellent Reserve Talent Project gyfyxkrc-2023-14
6 · The paper itself

Abstract

Asparagus officinalis (ASP) has antioxidation, anti-inflammatory, antiaging, and immune system-enhancing effects. We explored the preventive and therapeutic consequences of ASP on the brain damage elicited by fluorosis through network pharmacology and in vivo experimental validation. We ascertained the pharmaceutically active ingredients and drug targets of ASP from the Traditional Chinese Medicine Systems Pharmacology database, predicted the disease targets of fluorosis-induced brain injury using GeneCards and Online Mendelian Inheritance in Man databases, obtained target protein-protein interaction networks in the Search Tool for the Retrieval of Interacting Genes/Proteins database, used Cytoscape to obtain key targets and active ingredients, and conducted enrichment analyses of key targets in the Database for Annotation, Visualization and Integrated Discovery. Enrichment analyses showed that "mitogen-activated protein kinase" (MAPK), "phosphoinositide 3-kinase/protein kinase B" (PI3K-Akt), "nuclear factor-kappa B" (NF-κB), and the "neurotrophin signaling pathway" were the most enriched biological processes and signaling pathways. ASP could alleviate fluorosis-based injury, improve brain-tissue damage, increase urinary fluoride content, and improve oxidation levels and inflammatory-factor levels in the body. ASP could also reduce dental fluorosis, bone damage, fluoride concentrations in blood and bone, and accumulation of lipid peroxide. Upon ASP treatment, expression of silent information regulator (SIRT)1, brain-derived neurotrophic factor (BDNF), tropomyosin receptor kinase B (TrkB), MAPK, NF-κB, PI3K, Akt, and B-cell lymphoma-2 in rat brain tissue increased gradually, whereas that of Bax, caspase-3, and p53 decreased gradually. We demonstrated that ASP could regulate the brain damage caused by fluorosis through the SIRT1/BDNF/TrkB signaling pathway, and reported the possible part played by ASP in preventing and treating fluorosis.

Indexed as

Asparagus PlantBrain InjuriesFluoride PoisoningFluorosis, DentalPlant ExtractsAnimalsBrainFluoridesMaleNetwork PharmacologyProtein Interaction MapsRatsRats, Sprague-DawleySignal TransductionFluoridesPlant ExtractsAsparagusbrainfluorosisnetwork pharmacologySIRT1/BDNF/TrkB signaling pathway

Identifiers

PMID39041630
PMCPMC11911904

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.